Becker's Healthcare December 11, 2024
The introduction of ultra high-cost drugs, such as gene and cell therapies, is set to reshape pharmacy practices, according to a forecast published in the American Journal of Health-System Pharmacy from the American Society of Health-System Pharmacists and ASHP Foundation, its philanthropic arm.
As UHCDs offer new therapeutic possibilities, they also present challenges for health systems and pharmacy departments.
Here are five things to know:
- UHCDs, some of which can cost over $1 million per patient, will put financial strain on health systems. The forecast highlights the urgent need for pharmacies to develop sustainable financial models and strategic plans to address reimbursement complexities and ensure equitable access.
- Administering UHCDs requires specialized training and...
Today's Sponsors
Today's Sponsor